计算溶液所需的质量、体积或浓度。
CX-6258盐酸
- CAS编号: 1353859-00-3
- 分子式: C26H24ClN3O3.HCl
- 分子量: 498.4
- PubChem编号: 72201040
库存信息
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
C421345-1ml |
1ml |
现货 ![]() |
|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
C421345-1ml |
1ml |
现货 ![]() |
|
英文别名 | (3E)-5-chloro-3-[[5-[3-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)carbonyl]phenyl]-2-furanyl]methylene]-1,3-dihydro-2H-Indol-2-one,hydrochloride (1:1) |
---|---|
规格或纯度 | 10mM in DMSO |
英文名称 | CX-6258 HCl |
生化机理 | CX-6258 HCl 是一种强效口服泛 Pim 激酶抑制剂,对 Pim1、Pim2 和 Pim3 的 IC50 分别为 5 nM、25 nM 和 16 nM。 |
储存温度 | -80℃储存 |
运输条件 | 超低温冰袋运输 |
产品介绍 |
Information CX-6258 HCl is a potent, orally efficacious pan-Pim kinaseinhibitor withIC50of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively. Targets Pim1 (Cell-free assay); Pim3 (Cell-free assay); Pim2 (Cell-free assay) 5 nM; 16 nM; 25 nM In vitro CX-6258 shows antiproliferative activity against a panel of human cancer cell lines with IC50 of 0.02-3.7 μM, mostly sensitive to acute leukemia cell lines. Combinations of CX-6258 with doxorubicin (10:1 molar ratio) and CX-6258 with paclitaxel (100:1 molar ratio) produces synergistic cell killing with combination index (CI50) values equal to 0.4 and 0.56, respectively. CX-6258 causes dose dependent inhibition of the phosphorylation of two pro-survival proteins, Bad and 4E-BP1, at the Pim kinase specific sites S112 and S65 and T37/46, respectively. In vivo CX-6258 exhibits dose dependent efficacy in suppressing tumor growth in mice carrying MV-4-11 xenografts, with a 50 mg/kg dose producing 45% tumor growth inhibition (TGI) and a 100 mg/kg dose producing 75% TGI Cell Research(from reference) Cell lines:ALL, AML, CML, PML and MM cell lines Concentrations:~10 μM Incubation Time:96 hours |
IC50 | Pim1, IC50: 5 nM |
---|---|
ALogP | 4.416 |
HBD Count | 1 |
Rotatable Bond | 3 |
IUPAC Name | (3E)-5-chloro-3-[[5-[3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl]furan-2-yl]methylidene]-1H-indol-2-one;hydrochloride |
---|---|
INCHI | InChI=1S/C26H24ClN3O3.ClH/c1-29-10-3-11-30(13-12-29)26(32)18-5-2-4-17(14-18)24-9-7-20(33-24)16-22-21-15-19(27)6-8-23(21)28-25(22)31;/h2,4-9,14-16H,3,10-13H2,1H3,(H,28,31);1H/b22-16+; |
InChi Key | YYIMMVXTWBIEAG-YHLMHSEJSA-N |
Canonical SMILES | CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)C=C4C5=C(C=CC(=C5)Cl)NC4=O.Cl |
Isomeric SMILES | CN1CCCN(CC1)C(=O)C2=CC=CC(=C2)C3=CC=C(O3)/C=C/4\C5=C(C=CC(=C5)Cl)NC4=O.Cl |
PubChem CID | 72201040 |
分子量 | 498.4 |
DMSO(mg / mL) Max Solubility | 57 |
---|---|
DMSO(mM) Max Solubility | 114.3659711 |
Water(mg / mL) Max Solubility | 89 |
Water(mM) Max Solubility | 178.5714286 |
分子量 | 498.400 g/mol |
XLogP3 | |
氢键供体数Hydrogen Bond Donor Count | 2 |
氢键受体数Hydrogen Bond Acceptor Count | 4 |
可旋转键计数Rotatable Bond Count | 3 |
精确质量Exact Mass | 497.127 Da |
单同位素质量Monoisotopic Mass | 497.127 Da |
拓扑极表面积Topological Polar Surface Area | 65.800 Ų |
重原子数Heavy Atom Count | 34 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 774.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 1 |
共价键合单元计数Covalently-Bonded Unit Count | 2 |
Concentration | 9-11(mmol/L) |
---|---|
Proton NMR spectrum | Conforms to Structure |